In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 23rd, 2004 | 15 | No |
(+-)-N,2-Dimethyl-2-phenylsuccinimide
(RS)-1,3-Dimethyl-3-phenyl-2,5-pyrrolidindion
1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine
1,3-Dimethyl-3-phenyl-2,5-pyrrolidinedione
1,3-Dimethyl-3-phenyl-pyrrolidin-2,5-dione
1,3-dimethyl-3-phenylpyrrolidine-2,5-dione
1,3-Dimethyl-3-phenylsuccinimide
2,5-Pyrrolidinedione, 1,3-dimethyl-3-phenyl-
2,5-Pyrrolidinedione,1,3-dimethyl-3-phenyl-
2,5-Pyrrolidinedione,1,3-dimethyl-3-phenyl-, (+-)-
5-21-11-00209 (Beilstein Handbook Reference)
77-41-8; Celontin (TN); D00404; Mesuximide (INN); Methsuximide (USP)
Alpha-methyl-alpha-phenyl n-methyl succinimide
N,2-Dimethyl-2-phenylsuccinimide
N-methyl-alpha-methyl-alpha-phenylsuccinimide
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.34 | 1.56 | -8.17 | 0 | 3 | 0 | 37 | 203.241 | 1 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 2.13e+00 g/l | DrugBank-approved |
Therapy | anticonvulsant | SMDC Pharmakon |